Login / Signup

Current policies of non-commercial funders towards transparency in clinical trials.

Rafael Dal-Ré
Published in: European journal of clinical investigation (2024)
Keyphrases
  • clinical trial
  • public health
  • open label
  • double blind
  • phase iii
  • study protocol